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Fibrodysplasia ossificans progressiva (FOP) is an extremely rare genetic disorder characterised by extraskeletal ossification of
connective tissue. Affected individuals often become completely immobilised by their third decade of life. Amongst
numerous anaesthetic concerns, the airway management of patients with FOP may prove to be the greatest challenge. This
case report describes the anaesthetic management of a three-year-old girl with FOP and highlights the difficulties
encountered during airway management.
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Introduction
Fibrodysplasia ossificans progressiva (FOP) is a rare genetic dis-
order characterised by extraskeletal ossification of connective
tissue such as tendons, ligaments and the connective tissue in
skeletal muscle.1–3 Affected individuals are often completely
immobilised by their third decade of life.3 As the disease pro-
gresses, complications may arise secondary to thoracic insuffi-
ciency syndrome.4 However, in young children, the main
anaesthetic challenge may prove to be the airway manage-
ment.3,5,6 Only a few reports on the anaesthetic management
of young children with FOP exist.6 This case report describes
the anaesthetic management of a three-year-old girl with FOP.
Case report
Two days after a fall, a three-year-old girl developed a painful
swelling of her right knee and was unable to walk. She was
seen by a general practitioner who referred her to the orthopae-
dic outpatient department at our hospital. Following a clinical
and radiological examination the orthopaedic surgeon made
the diagnosis of fibrodysplasia ossificans progressiva with an
acute flare-up. The patient was scheduled for a semi-urgent
manipulation under anaesthesia and splinting of her right
knee the following day.
At birth, the mother had noted shortening of her daughter’s first
toes bilaterally but was not concerned about this. At the age of
two years the patient had developed a painful soft tissue swel-
ling over her back. A general practitioner was consulted but
no diagnosis was made, and no treatment was offered. By the
time she presented to our institution, about 15 months later,
the patient had developed significant kyphosis and mild scolio-
sis of her thoracic spine. Her neck was completely fixed in mild
flexion and her sternocleidomastoid muscles were ossified. She
had reduced mouth opening with an inter-incisor gap of 5 mm.
Despite this, she did not appear malnourished and she weighed
15.5 kg. She had significantly reduced range of motion in all
large joints with fixed flexion deformities in elbow, hip and
knee joints. Limited chest excursion was noted, and her breath-
ing was predominantly diaphragmatic. There was no history of
recurrent chest infections and no evidence of cardiac
Figure 1: Lateral chest radiograph showing soft tissue ossification and
ankylosis of cervical spine and upper limb joints. Ossified sternocleido-
mastoid muscles can also be seen.
Figure 2: Chest radiograph showing heterotopic ossification of soft
tissues and joints.
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dysfunction. She was not on any chronic medication and had no
previous surgical history. Radiographs (Figures 1–3) revealed
extensive ectopic bone formation.
Preoperative premedication was withheld. After careful position-
ing of the patient on the theatre bed, routine monitoring (elec-
trocardiogram, non-invasive blood pressure and pulse oximetry)
was placed and all pressure points were padded. A 22G intrave-
nous cannula was inserted without difficulty in a superficial vein
on the dorsum of her right hand. Anaesthesia was induced with
sevoflurane and oxygen. Oxymetazoline 0.025% drops were
then instilled in both nostrils. With the patient breathing spon-
taneously, an attempt was made at introducing a 2.8 mm
bronchofibrevideoscope (Olympus Medical Systems Corp,
Tokyo, Japan) nasally. However, the anatomy of the mid-nasal
vault was significantly distorted, so that the bronchoscope
could not be advanced. Fortunately, the presence of dental
decay provided enough space for the bronchoscope and the
subsequent insertion of the endotracheal tube orally over the
bronchoscope, without aggressive manipulation of the tempor-
omandibular joints. Once the vocal cords were adequately visu-
alised, 30 mg of propofol was administered intravenously and
the trachea was intubated with a size 4.5 uncuffed endotracheal
tube introduced over the bronchoscope. Pressure-controlled
ventilation was uneventful, and anaesthesia was maintained
with sevoflurane in an oxygen and air mixture.
Our patient’s vitals remained within normal limits throughout
the 45-minute procedure and she was extubated once fully
awake. Her stay in the recovery room and later in the ward
was uneventful. Six weeks after her surgery she sustained
another fall and injured her left arm. The radiographs revealed
a fracture of one of the heterotopic ossifications at the elbow
joint and no further surgery was required. Our patient is now
receiving care from a multidisciplinary team.
Discussion
FOP is an extremely rare autosomal dominant disorder7,8 with an
estimated prevalence of one affected individual per two million
population.9,10 Most new cases of FOP arise from sporadic
mutations in the activin A type I receptor (ACVRI) gene. ACVRI
is a bone morphogenic protein (BMP) type 1 receptor gene.2
The mutation causes activation of ACVRI, even in the absence
of its ligand. This uninhibited BMP signalling then initiates
new bone formation by promoting osteoclast formation.2,3,11
The heterotopic ossification that is characteristic of FOP may be
initiated by trauma or may occur sporadically.2 At birth, affected
individuals appear normal except for characteristic shortening
and congenital hallux valgus of their first toes bilaterally.3,12,13
During early childhood, painful soft tissue nodules appear,
which then progressively ossify. The initial lesions are confined
to the neck and back region but later spread distally.3,14 The het-
erotopic bone is morphologically identical to skeletal bone1 and
often severely restricts the mobility of affected individuals by
their third decade of life.3 Certain skeletal muscles including
the tongue, diaphragm and extraocular muscles are not affected
by FOP. Cardiac muscle and smooth muscle are also not
involved.3,8
The median age of survival of patients with FOP is 45 years and
the two leading causes of death are pulmonary infections and
right-sided heart failure secondary to thoracic insufficiency syn-
drome.4 Campbell et al.15 define thoracic insufficiency syndrome
as ‘the inability of the thorax to support normal respiration or
lung growth’.
Currently, there is no cure for FOP and the management of FOP
is predominantly supportive. Surgical removal of heterotopic
bone, osteotomies and surgical contracture releases are not rec-
ommended, as they may further induce the formation of hetero-
topic bone.3 Anecdotal evidence supports the early use of
glucocorticoids for the management of new flare-ups and the
use of anti-inflammatory agents for the management of
chronic discomfort.16 Prophylactic measures include the avoid-
ance of intramuscular injections,17 prevention of falls and the
administration of influenza vaccines.3 The influenza vaccines
should be administered subcutaneously and not during
periods of flare-up.3 Cardiac and respiratory function should
be evaluated periodically, and a multidisciplinary team should
be involved in the functional optimisation of patients with FOP.3
Anaesthetic considerations
Airway management
Most of the difficulty with the airway management of patients
with FOP arises from the effects of the disease on the temporo-
mandibular joints (TMJs) and the cervical spine.3,18,19 Ankylosis
of the TMJs is common in FOP3,5,14 and overstretching of the
jaw may cause enough trauma to the TMJs to result in localised
flare-up and further ossification.5 Neck stiffness may already be
present at an early age in children with FOP and usually pre-
cedes heterotopic bone formation.3,14,20 Numerous anatomical
abnormalities of the cervical spine have been identified in
patients with FOP and include tall, narrow vertebral processes
as well as large pedicles and spinous processes. Fusion of
facet joints and spinous processes between the second and
the seventh cervical vertebrae starts during early childhood.
This is a separate pathological process from the formation of
heterotopic bone.20 Flare-ups in the soft tissue of the neck, par-
ticularly in the submandibular area, may further compromise the
integrity of the upper airway.3,21
Anatomical deformity caused by joint ankylosis and ossification3
may interfere with optimal patient positioning during airway
management.22 Furthermore, the effects of the disease on the
thoracic spine and the chest wall may cause respiratory dysfunc-
tion4 and patients may therefore desaturate more rapidly than
anticipated.
In patients with FOP, there should generally not be any difficulty
in achieving an adequate seal during facemask ventilation. Diffi-
cult facemask ventilation may, however, still occur due to
Figure 3: Radiograph showing extensive ectopic soft tissue ossification
and ankylosis of the hip joints and lower lumbar spine.
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ankylosis of the TMJs. The reduced mouth opening may prevent
atraumatic oral airway insertion and reduced jaw protrusion may
interfere with the jaw thrust manoeuvre.22,23
Ankylosis of the TMJs and the cervical spine may make the inser-
tion of supraglottic airway devices as well as video-assisted and
direct laryngoscopy impossible.3,18,22 Forceful manipulation of
the upper airway should always be avoided, as this may
induce further flare-ups.5 Tumolo et al.6 therefore recommend
that direct laryngoscopy should not be performed during non-
emergency airway management in patients with FOP, even if
mouth opening is adequate.
Tracheostomy and transtracheal injections should be avoided in
patients with FOP to prevent ectopic ossification of the airway.6
An otolaryngologist should, however, be present in theatre in
case a surgical airway rescue procedure needs to be
performed.24
Several reports recommend nasotracheal fibreoptic intubation
in an awake or lightly sedated patient as the safest airway man-
agement technique in patients with FOP.5,24–26 This technique is
often not feasible in paediatric patients.6,24,27 Kilmartin et al.24
reviewed 42 cases in which general anaesthesia was adminis-
tered to patients with FOP presenting for dental treatment. An
awake fibreoptic intubation was performed in almost all adult
cases. In 14 of their 19 paediatric cases, fibreoptic intubation
was performed under sedation. Four paediatric cases,
however, required induction of anaesthesia, with maintenance
of spontaneous ventilation, prior to nasotracheal fibreoptic intu-
bation. The ages of these four patients ranged from 5 to 10
years.
In our three-year old patient, we elected to perform a volatile
induction to allow fibreoptic intubation during spontaneous
ventilation. However, nasal intubation was not possible due to
distorted anatomy of the mid-nasal vault. Inability to perform
nasal intubation due to distorted nasal anatomy in a patient
with FOP has previously been reported by Shipton et al.28 Fortu-
nately, the presence of dental decay in our patient provided
enough space to allow orotracheal fibreoptic intubation.
Caries, gingivitis and periodontitis are common in FOP patients
as ankylosis of the TMJs makes dental care more difficult.5 Once
the vocal cords had been adequately visualised, we adminis-
tered 30 mg of intravenous propofol, prior to intubating the
trachea. This provided ideal conditions for an atraumatic
intubation.
Thoracic insufficiency syndrome and cardiopulmonary
complications
In patients with FOP, thoracic insufficiency syndrome develops
due to a combination of costovertebral malformations and
early fixation of the chest wall.4,29 Ossification of paravertebral
soft tissue also impairs normal thoracic spine growth, which
may then result in the development of kyphoscoliosis. This
may further contribute to the thoracic deformity and dysfunc-
tion.4 Chest wall excursion is reduced early in the disease
process. Fortunately, the diaphragm is not affected by the
disease and diaphragmatic function alone is usually sufficient
for basal ventilatory requirements in patients with FOP, who
usually have reduced mobility.29 Lung function testing usually
reveals significantly reduced lung volumes with relatively
normal flow rates and normal capillary oxygen saturation.29,30
Pneumonia is the commonest cause of death in patients with
FOP.4
Physical examination of patients with FOP does not usually
reveal signs of cardiac failure, but evidence of right ventricular
dysfunction is often present on electrocardiogram (ECG). Kuss-
maul et al. identified a higher prevalence of right ventricular dys-
function on ECG in patients with FOP who were older, had
prolonged disease duration, had severe restrictive lung disease
and had higher haemoglobin concentrations.30 Cardiac muscle
is not affected directly by FOP, but cardiac connective tissue
may be affected. This may explain some of the cardiac conduc-
tion abnormalities that have been reported in the literature.29
Despite having some clinical evidence of thoracic insufficiency,
our patient had no history of recurrent chest infections and
her ECG showed no evidence of right ventricular dysfunction.
Mechanical ventilation was uncomplicated and there was no
need for postoperative ventilatory support.
Vascular access and regional anaesthesia
Subcutaneous injections and the careful insertion of superficial
intravenous catheters are not contraindicated in FOP. Traumatic
insertion of intravenous and arterial lines may, however, precipi-
tate heterotopic bone formation. Any form of intramuscular
injection may cause an acute flare-up of FOP at the injection
site and should be avoided.3,5,8,17,31 Regional anaesthesia is
therefore not advised,26 but the use of ultrasound guidance
may allow the safe placement of needles close to superficial
nerves without penetrating muscle and connective tissue.32
The musculoskeletal deformities present in patients with FOP
may also make it technically more difficult to insert needles
with precision.18,26 Furthermore, patients who have severe
deformities should be positioned carefully on the operating
table and pressure points should be padded to avoid soft
tissue trauma.6,24
Nutritional status
Ankylosis of the TMJs may prevent mastication3,6,8 and affected
individuals may be restricted to soft or liquid diets.33 Patients are
therefore often underweight and their general nutritional status
should be evaluated carefully.6
In conclusion, FOP is an extremely rare and devastating disease.
Even in young children, the disease may be severe enough to
present the attending anaesthetist with significant challenges.
A thorough preoperative assessment and meticulous anaesthe-
sia plan are essential. All patients with FOP should be managed
by a multidisciplinary team.
Disclosure statement – No conflict of interest was reported by the
author.
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